COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

Brief Intervention

Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study

10.1136/ard.62.8.764 ◽

2003 ◽

Vol 62 (8) ◽

pp. 764-766 ◽

Cited By ~ 29

Author(s):

J F Maillefert

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Controlled Study ◽

Structural Effects ◽

Double Blind

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

Arthritis Research & Therapy ◽

10.1186/ar3060 ◽

2010 ◽

Vol 12 (3) ◽

pp. R122 ◽

Cited By ~ 55

Author(s):

Vappu Rantalaiho ◽

Markku Korpela ◽

Leena Laasonen ◽

Hannu Kautiainen ◽

Salme Järvenpää ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Combination Therapy ◽

Disease Control ◽

Disease Modifying Antirheumatic Drug

Disease Modifying ◽

Therapy Trial ◽

Antirheumatic Drug Therapy ◽

THU0190 Long-Term Impact of Delaying Combination Therapy with Adalimumab Plus Methotrexate by 2 Years in Patients with Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial

10.1136/annrheumdis-2013-eular.718 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A227.3-A228 ◽

Cited By ~ 1

Author(s):

E. C. Keystone ◽

F. C. Breedveld ◽

D. van der Heijde ◽

R. Landewé ◽

S. Florentinus ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Long Term Impact

FRI0171 Achieving long-term comprehensive disease control with adalimumab and methotrexate in patients with early rheumatoid arthritis in the optima study:

10.1136/annrheumdis-2012-eular.2628 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 369.2-370 ◽

Cited By ~ 1

Author(s):

P. Emery ◽

J.S. Smolen ◽

R. Fleischmann ◽

R. van Vollenhoven ◽

S. Florentinus ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Disease Control ◽

Early Rheumatoid Arthritis

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial

10.1136/ard.62.4.291 ◽

2003 ◽

Vol 62 (4) ◽

pp. 291-296 ◽

Cited By ~ 59

Author(s):

A H Gerards

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Cyclosporin A ◽

Controlled Trial ◽

Double Blind

Combination therapy for early rheumatoid arthritis

Drug and Therapeutics Bulletin ◽

10.1136/dtb.2006.441181 ◽

2006 ◽

Vol 44 (11) ◽

pp. 81-85

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Early Rheumatoid Arthritis

Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial

Arthritis & Rheumatism ◽

10.1002/art.37916 ◽

2013 ◽

Vol 65 (6) ◽

pp. 1430-1438 ◽

Cited By ~ 88

Author(s):

Iris Navarro-Millán ◽

Christina Charles-Schoeman ◽

Shuo Yang ◽

Joan M. Bathon ◽

S. Louis Bridges ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Methotrexate Therapy

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice

Clinical Rheumatology ◽

10.1007/s10067-017-3962-5 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1189-1197 ◽

Cited By ~ 19

Author(s):

G. A. Versteeg ◽

L. M. M. Steunebrink ◽

H. E. Vonkeman ◽

P. M. ten Klooster ◽

A. E. van der Bijl ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Patient Reported Outcomes ◽

Daily Clinical Practice ◽

Treat To Target ◽

Patient Reported

60. Work Related Outcomes in Early Rheumatoid Arthritis Patients with Elevated Risk of Employment Loss: Results from Two Randomized Clinical Trials (Optima and Prowd) on the Effect of Adalimumab and Methotrexate Combination Therapy Versus Methotrexate Monotherapy Over 6 Months of Treatment

Rheumatology ◽

10.1093/rheumatology/keu098.015 ◽

2014 ◽

Vol 53 (suppl_1) ◽

pp. i78-i78

Author(s):

Paul Emery ◽

Josef Smolen ◽

Arijit Ganguli ◽

Sebastian Meerwein ◽

Yanjun Bao ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trials ◽

Combination Therapy ◽

Randomized Clinical Trials ◽

Elevated Risk ◽

Work Related

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

10.1136/annrheumdis-2012-201365 ◽

2012 ◽

Vol 72 (6) ◽

pp. 851-857 ◽

Cited By ~ 56

Author(s):

Marjatta Leirisalo-Repo ◽

Hannu Kautiainen ◽

Leena Laasonen ◽

Markku Korpela ◽

Markku J Kauppi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo